Insider · CIK 0001612842
Paul A. Wagner
officerdirector
Files at FBRX (Forte Biosciences, Inc.). First filing Nov 22, 2023, latest Dec 20, 2023.
In brief
Paul A. Wagner files SEC Form 4 as officer and director at FBRX (Forte Biosciences, Inc.). Since Nov 22, 2023, Paul A. Wagner has reported 5 open-market buys worth $75k and 0 open-market sells worth $0, the latest filed on Dec 20, 2023.
A track record needs three past buys with six months of prices behind them; Paul A. Wagner has 0, so none is measured yet.
The newest scored trade: bought $7,525 of FBRX on Dec 18, 2023, filed Dec 20, 2023, scored 15 (weak).
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
5 / 0
$75k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | FBRXbuy Forte Biosciences, Inc. | $7,525 10,000 shares | +1% | - | |
| 20Weak | FBRXbuy Forte Biosciences, Inc. | $15k 20,520 shares | +1% | - | |
| 20Weak | FBRXbuy Forte Biosciences, Inc. | $19k 29,776 shares | +2% | - | |
| 25Weak | FBRXbuy Forte Biosciences, Inc. | $30k 51,203 shares | +3% | - | |
| 10Weak | FBRXbuy Forte Biosciences, Inc. | $3,220 7,366 shares | +0% | - |
Transactions
The newest 50 of 57 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | UTender of shares Common Stock | -85,482 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -16,866 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -5,400 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -11,999 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -44,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -920,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -270,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -500,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -2,500 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -180,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -3,511 | - | - | 0 | Aug 27, 2026 |
| Jul 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | - | - | 85,580 | Jul 6, 2026 |
| Jul 1, 2026 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -98 | $21.32 | $2,089 | 85,482 | Jul 6, 2026 |
| Jul 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 2,500 | Jul 6, 2026 |
| Jun 16, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Jun 17, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | - | - | 84,428 | Apr 3, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -98 | $24.86 | $2,436 | 84,330 | Apr 3, 2026 |
| Apr 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 3,750 | Apr 3, 2026 |
| Jan 12, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +270,000 | $0.00 | $0 | 270,000 | Jan 13, 2026 |
| Jan 12, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +180,000 | $0.00 | $0 | 180,000 | Jan 13, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 83,342 | Jan 2, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -164 | $27.27 | $4,472 | 83,178 | Jan 2, 2026 |
| Jan 1, 2026 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 5,000 | Jan 2, 2026 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 82,190 | Oct 2, 2025 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -98 | $14.52 | $1,423 | 82,092 | Oct 2, 2025 |
| Oct 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 6,250 | Oct 2, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 81,038 | Jul 3, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -98 | $12.44 | $1,219 | 80,940 | Jul 3, 2025 |
| Jul 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 7,500 | Jul 3, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 79,806 | Apr 2, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -18 | $7.43 | $134 | 79,788 | Apr 2, 2025 |
| Apr 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 8,750 | Apr 2, 2025 |
| Mar 20, 2025 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +920,000 | $0.00 | $0 | 920,000 | Mar 21, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 78,720 | Jan 2, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -164 | $22.71 | $3,724 | 78,556 | Jan 2, 2025 |
| Jan 1, 2025 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 10,000 | Jan 2, 2025 |
| Jul 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +31,250 | $0.00 | $0 | 1,910,424 | Jul 3, 2024 |
| Jul 1, 2024 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -2,453 | $0.55 | $1,339 | 1,907,971 | Jul 3, 2024 |
| Jul 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -31,250 | $0.00 | $0 | 312,500 | Jul 3, 2024 |
| Apr 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +31,250 | $0.00 | $0 | 1,881,627 | Apr 2, 2024 |
| Apr 1, 2024 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -2,453 | $0.71 | $1,736 | 1,879,174 | Apr 2, 2024 |
| Apr 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -31,250 | $0.00 | $0 | 343,750 | Apr 2, 2024 |
| Mar 21, 2024 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,100,000 | $0.00 | $0 | 1,100,000 | Mar 25, 2024 |
| Jan 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Common Stock | +31,250 | $0.00 | $0 | 1,854,486 | Jan 3, 2024 |
| Jan 1, 2024 | FBRX Forte Biosciences, Inc. | FTax withholding Common Stock | -4,109 | $0.82 | $3,376 | 1,850,377 | Jan 3, 2024 |
| Jan 1, 2024 | FBRX Forte Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -31,250 | $0.00 | $0 | 375,000 | Jan 3, 2024 |
| Dec 18, 2023 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +10,000 | $0.75 | $7,525 | 1,823,236 | Dec 20, 2023 |
| Dec 13, 2023 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +10,520 | $0.70 | $7,351 | 1,803,236 | Dec 15, 2023 |
| Dec 14, 2023 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +10,000 | $0.72 | $7,200 | 1,813,236 | Dec 15, 2023 |
| Dec 11, 2023 | FBRX Forte Biosciences, Inc. | POpen-market purchase Common Stock | +25,000 | $0.65 | $16k | 1,787,940 | Dec 12, 2023 |
50 of 57 rows shown.
Questions about Paul A. Wagner
Answered from the filings on this page, as of the latest one.
Is Paul A. Wagner buying or selling?
Not in the last 12 months. Paul A. Wagner's latest open-market trade on SEC Form 4 was bought $7,525 of FBRX on Dec 18, 2023.
How did Paul A. Wagner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul A. Wagner has 0.
Where does Paul A. Wagner file Form 4?
Paul A. Wagner has filed Form 4 at FBRX (Forte Biosciences, Inc.) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.